This is a community-generated profile. If you would like to claim it, please .
Viamet Pharmaceuticals Funding
$0
33 rounds
Viamet Pharmaceuticals is active in the following markets / industries: biotechnology. The company has secured funding across 3 rounds and is valued at $0. Their most recent funding was raised on October 22, 2014.
Funding Rounds
B
$25000000A
$4000000Investors of Viamet Pharmaceuticals
Hatteras Venture Partners
Novartis Venture Fund
Astellas Venture Management
Lilly Ventures
Intersouth Partners
U.S. Department of Defense
Woodford Investment Management
Rounds
D